Popular Stories
- Arcutis Biotherapeutics (N
- Nexgel: Bringing Innovatio
- Ekso Bionics: Advancing Ra
- Esperion: Revolutionizing
- AMSC: Restructuring the Po
- Harrow Inc: Envisioning a
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

What causes neurodegenerative diseases Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
ANAVEX®2-73: A Potential Blockbuster Drug in the Making!
ANAVEX®2-73: A Potential Blockbuster Drug in the Making!

Anavex Life Sciences Corp (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company that is developing a pipeline of therapeutic candidates that target the Central Nervous System (CNS) by leveraging its expertise in precision genetic medicine. The Company has announced that its predictive biomarker of response established...

30 June, 2021 0 Comments
Can Annovis Bio Deliver a Breakthrough in Alzheimer's Disease?
Can Annovis Bio Deliver a Breakthrough in Alzheimer’s Disease?

Annovis Bio, Inc. (NYSE: ANVS) is a clinical-stage biotechnology Company that is developing a pipeline of drugs that target the treatment of Alzheimer’s and other neurodegenerative diseases through improvement of Axonal Transport. The Company is working on therapeutics for Alzheimer’s disease (AD), Parkinson’s disease (PD),...

18 June, 2021 0 Comments
WordPress Video Lightbox Plugin